This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
BioMarin Pharmaceutical Inc.
Drug Names(s): Neutralase
Description: Neutralase, or heparinase I, is a carbohydrate-modifying enzyme that cleaves heparin and inactivates it. It is a potential alternative to protamine sulfate used currently to reverse heparin-induced anti-coagulation during coronary artery bypass grafting (CABG).
Additional information available to subscribers only: